Morgan Health backs Lantern with $30M investment

Advertisement

Morgan Health, a division of JPMorganChase, is backing specialty care platform Lantern with a $30 million investment to expand its reach among employers and health plans.

Echo Health Ventures, which invests on behalf of Blue Cross Blue Shield-affiliated health plans, also participated in the funding round. Lantern said the investment will support continued growth across public and private employers.

Lantern’s platform connects patients to high-quality providers through its “Network of Excellence” model, focusing on high-cost areas such as surgery, cancer and infusions. The company said its approach can lower costs and improve outcomes, including savings of up to $20 per employee per month and negotiated rates up to 55% below average commercial reimbursement, according to a March 19 news release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement